Efficacy and Safety of Wei Bi Mei, a Chinese Herb Compound, as an Alternative to Bismuth for Eradication of Helicobacter pylori

Bismuth-containing quadruple therapy has been recommended as the first line of treatment in areas of high clarithromycin or metronidazole resistance. However, safety concerns of bismuth agents have long been raised. We first assessed the efficacy and safety of Wei Bi Mei granules, which are bismuth...

Full description

Saved in:
Bibliographic Details
Published inEvidence-based complementary and alternative medicine Vol. 2018; no. 2018; pp. 1 - 10
Main Authors Xu, HuFeng, Zhang, Shutian, Wang, QinQin, Sun, YiLin, Zhao, Xin, Wang, Yongjun, Guo, Shuilong, Zhu, Shengtao, Meng, FanDong, Li, Lei, Zhang, Yan
Format Journal Article
LanguageEnglish
Published Cairo, Egypt Hindawi Publishing Corporation 01.01.2018
Hindawi
John Wiley & Sons, Inc
Hindawi Limited
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Bismuth-containing quadruple therapy has been recommended as the first line of treatment in areas of high clarithromycin or metronidazole resistance. However, safety concerns of bismuth agents have long been raised. We first assessed the efficacy and safety of Wei Bi Mei granules, which are bismuth compounds consisting of three synthetic drugs and five medicinal herbs, compared to bismuth aluminate and colloidal bismuth subcitrate (CBS) in H. pylori-infected mouse model. We then used atomic fluorescence spectroscopy and autometallography to measure the accumulation of three bismuth agents in the brain, heart, liver, and kidneys in adult Sprague-Dawley rats. We also evaluated the safety of bismuth agents by conducting clinical biochemistry tests in blood samples of experimental animals. Wei Bi Mei granules exhibited the highest efficacy of anti-H. pylori activity and yielded the lowest bismuth accumulation when compared to CBS and bismuth aluminate. Our findings show that Wei Bi Mei granules are a safe Chinese medicinal herb with potent anti-H. pylori activity and can be considered as an alternative to current bismuth compounds. Thus, Wei Bi Mei granules merit further evaluation, particularly with regard to efficacy and safety when they are combined with other H. pylori eradication medications in the clinical setting.
AbstractList Bismuth-containing quadruple therapy has been recommended as the first line of treatment in areas of high clarithromycin or metronidazole resistance. However, safety concerns of bismuth agents have long been raised. We first assessed the efficacy and safety of Wei Bi Mei granules, which are bismuth compounds consisting of three synthetic drugs and five medicinal herbs, compared to bismuth aluminate and colloidal bismuth subcitrate (CBS) in H. pylori-infected mouse model. We then used atomic fluorescence spectroscopy and autometallography to measure the accumulation of three bismuth agents in the brain, heart, liver, and kidneys in adult Sprague-Dawley rats. We also evaluated the safety of bismuth agents by conducting clinical biochemistry tests in blood samples of experimental animals. Wei Bi Mei granules exhibited the highest efficacy of anti-H. pylori activity and yielded the lowest bismuth accumulation when compared to CBS and bismuth aluminate. Our findings show that Wei Bi Mei granules are a safe Chinese medicinal herb with potent anti-H. pylori activity and can be considered as an alternative to current bismuth compounds. Thus, Wei Bi Mei granules merit further evaluation, particularly with regard to efficacy and safety when they are combined with other H. pylori eradication medications in the clinical setting.
Bismuth-containing quadruple therapy has been recommended as the first line of treatment in areas of high clarithromycin or metronidazole resistance. However, safety concerns of bismuth agents have long been raised. We first assessed the efficacy and safety of Wei Bi Mei granules, which are bismuth compounds consisting of three synthetic drugs and five medicinal herbs, compared to bismuth aluminate and colloidal bismuth subcitrate (CBS) in H. pylori -infected mouse model. We then used atomic fluorescence spectroscopy and autometallography to measure the accumulation of three bismuth agents in the brain, heart, liver, and kidneys in adult Sprague-Dawley rats. We also evaluated the safety of bismuth agents by conducting clinical biochemistry tests in blood samples of experimental animals. Wei Bi Mei granules exhibited the highest efficacy of anti- H. pylori activity and yielded the lowest bismuth accumulation when compared to CBS and bismuth aluminate. Our findings show that Wei Bi Mei granules are a safe Chinese medicinal herb with potent anti- H. pylori activity and can be considered as an alternative to current bismuth compounds. Thus, Wei Bi Mei granules merit further evaluation, particularly with regard to efficacy and safety when they are combined with other H. pylori eradication medications in the clinical setting.
Bismuth-containing quadruple therapy has been recommended as the first line of treatment in areas of high clarithromycin or metronidazole resistance. However, safety concerns of bismuth agents have long been raised. We first assessed the efficacy and safety of Wei Bi Mei granules, which are bismuth compounds consisting of three synthetic drugs and five medicinal herbs, compared to bismuth aluminate and colloidal bismuth subcitrate (CBS) in -infected mouse model. We then used atomic fluorescence spectroscopy and autometallography to measure the accumulation of three bismuth agents in the brain, heart, liver, and kidneys in adult Sprague-Dawley rats. We also evaluated the safety of bismuth agents by conducting clinical biochemistry tests in blood samples of experimental animals. Wei Bi Mei granules exhibited the highest efficacy of anti- activity and yielded the lowest bismuth accumulation when compared to CBS and bismuth aluminate. Our findings show that Wei Bi Mei granules are a safe Chinese medicinal herb with potent anti- activity and can be considered as an alternative to current bismuth compounds. Thus, Wei Bi Mei granules merit further evaluation, particularly with regard to efficacy and safety when they are combined with other eradication medications in the clinical setting.
Audience Academic
Author Meng, FanDong
Zhang, Shutian
Guo, Shuilong
Zhu, Shengtao
Zhao, Xin
Xu, HuFeng
Wang, QinQin
Zhang, Yan
Sun, YiLin
Li, Lei
Wang, Yongjun
AuthorAffiliation 2 Department of Digestive Diseases, Affiliated Hospital for Wei Fang Medical University, Wei Fang 261031, China
4 Department of Ultrapathology of Beijing Neurosurgical Institute, Beijing 100050, China
5 Department of Ultrapathology of Beijing Neurosurgical Institute, Affiliated Bayi Brain Hospital, Army General Hospital of PLA, Beijing 100700, China
6 The Animal Experiment Center of Beijing Friendship Hospital, Capital Medical University, Beijing 100050, China
1 Department of Gastroenterology, Beijing Friendship Hospital, Capital Medical University, National Clinical Research Center for Digestive Diseases, Beijing Digestive Disease Center, Beijing Key Laboratory for Precancerous Lesion of Digestive Diseases, Beijing 100050, China
3 Key Laboratory of Safety Risk Assessment of Ministry of Health, China National Center for Food Safety Risk Assessment, Beijing 100021, China
AuthorAffiliation_xml – name: 1 Department of Gastroenterology, Beijing Friendship Hospital, Capital Medical University, National Clinical Research Center for Digestive Diseases, Beijing Digestive Disease Center, Beijing Key Laboratory for Precancerous Lesion of Digestive Diseases, Beijing 100050, China
– name: 5 Department of Ultrapathology of Beijing Neurosurgical Institute, Affiliated Bayi Brain Hospital, Army General Hospital of PLA, Beijing 100700, China
– name: 3 Key Laboratory of Safety Risk Assessment of Ministry of Health, China National Center for Food Safety Risk Assessment, Beijing 100021, China
– name: 6 The Animal Experiment Center of Beijing Friendship Hospital, Capital Medical University, Beijing 100050, China
– name: 2 Department of Digestive Diseases, Affiliated Hospital for Wei Fang Medical University, Wei Fang 261031, China
– name: 4 Department of Ultrapathology of Beijing Neurosurgical Institute, Beijing 100050, China
Author_xml – sequence: 1
  fullname: Xu, HuFeng
– sequence: 2
  fullname: Zhang, Shutian
– sequence: 3
  fullname: Wang, QinQin
– sequence: 4
  fullname: Sun, YiLin
– sequence: 5
  fullname: Zhao, Xin
– sequence: 6
  fullname: Wang, Yongjun
– sequence: 7
  fullname: Guo, Shuilong
– sequence: 8
  fullname: Zhu, Shengtao
– sequence: 9
  fullname: Meng, FanDong
– sequence: 10
  fullname: Li, Lei
– sequence: 11
  fullname: Zhang, Yan
BackLink https://www.ncbi.nlm.nih.gov/pubmed/29636776$$D View this record in MEDLINE/PubMed
BookMark eNqNkUuP0zAURiM0iHnAjjWyxAaJKeNnHG-QSlUo0iAWgGBnOc711KPULnYyqCv-Oo5aOsCKlSPdc4-d7zuvTkIMUFVPCX5FiBBXFJPmijOKKVEPqjMiOZlx2jQnx2_57bQ6z_kWY6qklI-qU6pqVktZn1U_l855a-wOmdChT8bBsEPRoa_g0RuPPoC_RAYt1j5ABrSC1KJF3GzjGLoyyGULzfsBUjCDvwM0xLKVN-OwRi4mtEymK_bBxzBJV9B7G1tjywLa7vqY_OPqoTN9hieH86L68nb5ebGaXX98934xv55ZrtQwEy1tDZGUSFtLYVRHaxCMcyUMrwlx0LWUNWVsrHKAJW4sb1XXio5L17COXVSv997t2G6gsxCGZHq9TX5j0k5H4_Xfk-DX-ibeadEwWnIughcHQYrfR8iD3vhsoe9NgDhmXfLnmNSMqYI-_we9jWNJqJ-o0gGtpRL31I3pQfvgYrnXTlI9rzFnhAlBCnW5p2yKOSdwxycTrKf-9dS_PvRf8Gd__uYR_l14AV7ugdJoZ374_9RBYcCZe7qgJRT2C511wcs
CitedBy_id crossref_primary_10_1002_smll_202308286
crossref_primary_10_13105_wjma_v8_i2_98
crossref_primary_10_1155_2020_9154738
crossref_primary_10_1155_2020_2679034
crossref_primary_10_3389_fmicb_2022_1033201
crossref_primary_10_12998_wjcc_v9_i35_10781
Cites_doi 10.1007/s100960050412
10.1136/gutjnl-2016-312288
10.1007/bf03259915
10.1159/000350719
10.1111/hel.12311
10.1039/c4nr01405g
10.1046/j.1365-2036.1996.22163000.x
10.1186/s13099-016-0091-7
10.1007/BF02098030
10.2147/IJNRD.S54818
10.1111/j.1523-5378.2010.00788.x
10.1016/S0016-5085(97)70155-0
10.1271/bbb.120690
10.1021/ja2013278
10.1111/j.1742-7843.2005.pto_973132.x
10.1177/002215540004801107
10.3748/wjg.v16.i40.5118
10.23736/S1121-421X.17.02369-8
10.1111/apt.13346
10.1136/bmj.2.6094.1052
10.1136/gut.2009.192757
10.1111/j.1523-5378.2010.00779.x
10.1111/hel.12332
10.1371/journal.pone.0035072
10.1159/000199555
10.3168/jds.S0022-0302(82)82260-1
10.1016/j.jep.2012.03.001
ContentType Journal Article
Copyright Copyright © 2018 Lei Li et al.
COPYRIGHT 2018 John Wiley & Sons, Inc.
Copyright © 2018 Lei Li et al.; This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Copyright © 2018 Lei Li et al. 2018
Copyright_xml – notice: Copyright © 2018 Lei Li et al.
– notice: COPYRIGHT 2018 John Wiley & Sons, Inc.
– notice: Copyright © 2018 Lei Li et al.; This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
– notice: Copyright © 2018 Lei Li et al. 2018
DBID ADJCN
RHU
RHW
RHX
NPM
AAYXX
CITATION
3V.
7RV
7T5
7TO
7X7
7XB
88G
8AO
8FI
8FJ
8FK
8G5
ABUWG
AFKRA
AZQEC
BENPR
CCPQU
DWQXO
FYUFA
GHDGH
GNUQQ
GUQSH
H94
K9.
KB0
M0S
M2M
M2O
MBDVC
NAPCQ
PIMPY
PQEST
PQQKQ
PQUKI
PRINS
PSYQQ
Q9U
7X8
5PM
DOI 10.1155/2018/4320219
DatabaseName الدوريات العلمية والإحصائية - e-Marefa Academic and Statistical Periodicals
Hindawi Publishing Complete
Hindawi Publishing Subscription Journals
Open Access: Hindawi Publishing
PubMed
CrossRef
ProQuest Central (Corporate)
Nursing & Allied Health Database
Immunology Abstracts
Oncogenes and Growth Factors Abstracts
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Psychology Database (Alumni)
ProQuest Pharma Collection
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
Research Library (Alumni Edition)
ProQuest Central (Alumni Edition)
ProQuest Central UK/Ireland
ProQuest Central Essentials
AUTh Library subscriptions: ProQuest Central
ProQuest One Community College
ProQuest Central
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Central Student
Research Library Prep
AIDS and Cancer Research Abstracts
ProQuest Health & Medical Complete (Alumni)
Nursing & Allied Health Database (Alumni Edition)
Health & Medical Collection (Alumni Edition)
Psychology Database
Research Library
Research Library (Corporate)
Nursing & Allied Health Premium
Publicly Available Content Database
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
ProQuest One Psychology
ProQuest Central Basic
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle PubMed
CrossRef
Publicly Available Content Database
ProQuest One Psychology
Research Library Prep
ProQuest Central Student
Oncogenes and Growth Factors Abstracts
ProQuest Central Essentials
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
Research Library (Alumni Edition)
ProQuest Pharma Collection
ProQuest Central China
ProQuest Central
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
ProQuest Central Korea
AIDS and Cancer Research Abstracts
ProQuest Research Library
ProQuest Central Basic
ProQuest One Academic Eastern Edition
ProQuest Nursing & Allied Health Source
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
ProQuest Psychology Journals (Alumni)
ProQuest Hospital Collection (Alumni)
Nursing & Allied Health Premium
ProQuest Health & Medical Complete
ProQuest Psychology Journals
ProQuest One Academic UKI Edition
Immunology Abstracts
ProQuest Nursing & Allied Health Source (Alumni)
ProQuest One Academic
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList
CrossRef
Publicly Available Content Database


PubMed
Database_xml – sequence: 1
  dbid: RHX
  name: Open Access: Hindawi Publishing
  url: http://www.hindawi.com/journals/
  sourceTypes: Publisher
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: BENPR
  name: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1741-4288
Editor Nammi, Srinivas
Editor_xml – sequence: 1
  givenname: Srinivas
  surname: Nammi
  fullname: Nammi, Srinivas
– fullname: Srinivas Nammi
EndPage 10
ExternalDocumentID A604313551
10_1155_2018_4320219
29636776
1155153
Genre Journal Article
GeographicLocations China
Beijing China
GeographicLocations_xml – name: China
– name: Beijing China
GroupedDBID ---
04C
18M
24P
29G
2WC
3V.
4.4
53G
5GY
5VS
6PF
7RV
7X7
8AO
8FI
8FJ
8G5
AAFWJ
AAJEY
AAWTL
ABQTQ
ABUWG
ACGFO
ACPRK
ADBBV
ADJCN
ADOJX
ADRAZ
AENEX
AFKRA
AFRAH
AHMBA
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AOIJS
AZQEC
BAWUL
BCNDV
BENPR
BEYMZ
BKEYQ
BMSDO
BPHCQ
BVXVI
C1A
CAG
CCPQU
CKLRP
COF
CS3
DIK
DWQXO
E3Z
EAL
EBD
EBS
ECF
ECT
EIHBH
EJD
F5P
FYUFA
GNUQQ
GROUPED_DOAJ
GUQSH
GX1
H13
HMCUK
HYE
IAO
IEA
IHR
IHW
IPNFZ
ITC
KQ8
M2M
M2O
M48
M49
M~E
N9A
NAPCQ
NU-
O5R
O5S
OK1
OVD
P2P
PGMZT
PIMPY
PQQKQ
PROAC
PSYQQ
RHX
RIG
RNS
RPM
RXO
TEORI
TR2
UKHRP
WOQ
WOW
XSB
ZKX
RHU
RHW
NPM
AAYXX
CITATION
7T5
7TO
7XB
8FK
H94
K9.
MBDVC
PQEST
PQUKI
PRINS
Q9U
7X8
5PM
ID FETCH-LOGICAL-c499t-5b2ba17217c675a9d26e534495a4611fedb238217ac9fe0708c4b9db5d47f83d3
IEDL.DBID RPM
ISSN 1741-427X
IngestDate Tue Sep 17 20:54:23 EDT 2024
Sun Sep 29 07:30:16 EDT 2024
Thu Oct 10 18:34:58 EDT 2024
Wed Oct 16 18:02:29 EDT 2024
Thu Sep 26 21:00:04 EDT 2024
Wed Oct 16 01:01:27 EDT 2024
Sun Jun 02 18:54:53 EDT 2024
Thu Sep 12 21:20:48 EDT 2024
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 2018
Language English
License This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c499t-5b2ba17217c675a9d26e534495a4611fedb238217ac9fe0708c4b9db5d47f83d3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Academic Editor: Srinivas Nammi
ORCID 0000-0003-3687-7333
0000-0001-6705-9339
0000-0003-2356-4397
OpenAccessLink https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5832115/
PMID 29636776
PQID 2002926795
PQPubID 2037463
PageCount 10
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_5832115
proquest_miscellaneous_2024016339
proquest_journals_2002926795
gale_infotracmisc_A604313551
crossref_primary_10_1155_2018_4320219
pubmed_primary_29636776
hindawi_primary_10_1155_2018_4320219
emarefa_primary_1155153
PublicationCentury 2000
PublicationDate 2018-01-01
PublicationDateYYYYMMDD 2018-01-01
PublicationDate_xml – month: 01
  year: 2018
  text: 2018-01-01
  day: 01
PublicationDecade 2010
PublicationPlace Cairo, Egypt
PublicationPlace_xml – name: Cairo, Egypt
– name: United States
– name: New York
PublicationTitle Evidence-based complementary and alternative medicine
PublicationTitleAlternate Evid Based Complement Alternat Med
PublicationYear 2018
Publisher Hindawi Publishing Corporation
Hindawi
John Wiley & Sons, Inc
Hindawi Limited
Publisher_xml – name: Hindawi Publishing Corporation
– name: Hindawi
– name: John Wiley & Sons, Inc
– name: Hindawi Limited
References e_1_2_7_5_2
e_1_2_7_3_2
Chen J. Y. (e_1_2_7_17_2) 2017; 24
e_1_2_7_2_2
e_1_2_7_9_2
e_1_2_7_8_2
e_1_2_7_7_2
e_1_2_7_6_2
e_1_2_7_19_2
Liu Y. J. (e_1_2_7_33_2) 2015; 11129
e_1_2_7_16_2
e_1_2_7_15_2
e_1_2_7_1_2
e_1_2_7_14_2
e_1_2_7_13_2
e_1_2_7_12_2
e_1_2_7_11_2
e_1_2_7_10_2
e_1_2_7_26_2
e_1_2_7_27_2
e_1_2_7_29_2
Wang J. G. (e_1_2_7_32_2) 2015; 12112
e_1_2_7_25_2
e_1_2_7_24_2
e_1_2_7_30_2
e_1_2_7_23_2
e_1_2_7_31_2
e_1_2_7_22_2
e_1_2_7_21_2
e_1_2_7_20_2
Qiao W. (e_1_2_7_18_2) 2016; 36
Prabjone R. (e_1_2_7_28_2) 2006; 35
Hunt R. H. (e_1_2_7_4_2) 2010
References_xml – ident: e_1_2_7_20_2
  doi: 10.1007/s100960050412
– ident: e_1_2_7_5_2
  doi: 10.1136/gutjnl-2016-312288
– volume: 11129
  year: 2015
  ident: e_1_2_7_33_2
  article-title: Observation on The Efficacy of Compound bismuth and Mahnesium Granules Combined with Itopride on Chronic Gastritus with Dyspepsia Symptoms
  publication-title: China Foreign Medical Treatment
  contributor:
    fullname: Liu Y. J.
– volume: 24
  start-page: 46
  year: 2017
  ident: e_1_2_7_17_2
  article-title: Effect of compound Bismuth Magnesium quadruple therapy in the treatment of Hp-related peptic ulcer
  publication-title: China Modern Medicine
  contributor:
    fullname: Chen J. Y.
– ident: e_1_2_7_10_2
  doi: 10.1007/bf03259915
– ident: e_1_2_7_9_2
  doi: 10.1159/000350719
– ident: e_1_2_7_11_2
  doi: 10.1111/hel.12311
– ident: e_1_2_7_14_2
  doi: 10.1039/c4nr01405g
– ident: e_1_2_7_30_2
  doi: 10.1046/j.1365-2036.1996.22163000.x
– ident: e_1_2_7_3_2
  doi: 10.1186/s13099-016-0091-7
– ident: e_1_2_7_31_2
  doi: 10.1007/BF02098030
– ident: e_1_2_7_29_2
  doi: 10.2147/IJNRD.S54818
– ident: e_1_2_7_8_2
  doi: 10.1111/j.1523-5378.2010.00788.x
– ident: e_1_2_7_12_2
  doi: 10.1016/S0016-5085(97)70155-0
– ident: e_1_2_7_26_2
  doi: 10.1271/bbb.120690
– volume: 36
  start-page: 25
  year: 2016
  ident: e_1_2_7_18_2
  article-title: Effects of Chinese medicine portions of Weibimei on cell cycle regulation and tumor inhibition in nude mice
  publication-title: Chinese Journal of Biochemical Pharmaceutics
  contributor:
    fullname: Qiao W.
– ident: e_1_2_7_21_2
  doi: 10.1021/ja2013278
– ident: e_1_2_7_15_2
  doi: 10.1111/j.1742-7843.2005.pto_973132.x
– volume: 12112
  year: 2015
  ident: e_1_2_7_32_2
  article-title: Effect of Compound Bismush and Magnesium Granules Combined with Triple Therapy for Treament of Hp Positive Duodenal Bulbar Ulcer
  publication-title: China Medical Herald
  contributor:
    fullname: Wang J. G.
– ident: e_1_2_7_16_2
  doi: 10.1177/002215540004801107
– ident: e_1_2_7_6_2
  doi: 10.3748/wjg.v16.i40.5118
– volume-title: World Gastroenterology Organisation Global Guidelines, Helicobacter pylori in Developing Countries
  year: 2010
  ident: e_1_2_7_4_2
  contributor:
    fullname: Hunt R. H.
– ident: e_1_2_7_7_2
  doi: 10.23736/S1121-421X.17.02369-8
– ident: e_1_2_7_22_2
  doi: 10.1111/apt.13346
– ident: e_1_2_7_24_2
  doi: 10.1136/bmj.2.6094.1052
– ident: e_1_2_7_25_2
  doi: 10.1136/gut.2009.192757
– volume: 35
  start-page: 359
  year: 2006
  ident: e_1_2_7_28_2
  article-title: Anti-inflammatory effects of Aloe vera on leukocyte-endothelium interaction in the gastric microcirculation of Helicobacter pylori-infected rats
  publication-title: Clinical Hemorheology and Microcirculation
  contributor:
    fullname: Prabjone R.
– ident: e_1_2_7_2_2
  doi: 10.1111/j.1523-5378.2010.00779.x
– ident: e_1_2_7_1_2
  doi: 10.1111/hel.12332
– ident: e_1_2_7_13_2
  doi: 10.1371/journal.pone.0035072
– ident: e_1_2_7_19_2
  doi: 10.1159/000199555
– ident: e_1_2_7_23_2
  doi: 10.3168/jds.S0022-0302(82)82260-1
– ident: e_1_2_7_27_2
  doi: 10.1016/j.jep.2012.03.001
SSID ssj0029777
Score 2.255586
Snippet Bismuth-containing quadruple therapy has been recommended as the first line of treatment in areas of high clarithromycin or metronidazole resistance. However,...
Bismuth‐containing quadruple therapy has been recommended as the first line of treatment in areas of high clarithromycin or metronidazole resistance. However,...
SourceID pubmedcentral
proquest
gale
crossref
pubmed
hindawi
emarefa
SourceType Open Access Repository
Aggregation Database
Index Database
Publisher
StartPage 1
SubjectTerms Accumulation
Acorus
Antibacterial agents
Antibiotics
Atomic beam spectroscopy
Bismuth
Bismuth compounds
Clarithromycin
Comparative analysis
Developing countries
Disease
Drug resistance
Drugs
Fluorescence
Fluorescence spectroscopy
Gastric cancer
Granular materials
Helicobacter infections
Helicobacter pylori
Herbal medicine
Herbs
Hospitals
Infections
Kidneys
Laboratory animals
LDCs
Liver
Medicinal herbs
Medicinal plants
Medicine, Botanic
Medicine, Herbal
Metronidazole
Rats
Risk assessment
Safety
Ulcers
SummonAdditionalLinks – databaseName: Open Access: Hindawi Publishing
  dbid: RHX
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1Nj9MwELVgpUVcEN8EChqk5UZEk9hxciyoqwqpHIAVvUX-mKiR2HS1SUF74q8z07iBLkhwS2Q7tjIez3uO80aIk6kzvpaWPA3J3WQqfVxYo2M9zZ0yxlIQ5X3I5Yd8cSbfr9QqiCR1f37Cp2hH9Dwp3kjO883ynjeLgiXyPy5WI68iCKOH_x6JDqV6tT_ffq3tQeQ5xnNDF2ZciY_XzIG_N39DmtcPTP4WgU7vijsBOsJssPU9cQPb--LWMnwcfyB-zFkOwrgrMK2HT6bG_go2NXzBBt42sMTmNRjghNnYISzofQKvBpxXiQo6agWzr2F_8BtCv6FW3fm2XwMBW5hfGh_29_ihFK5oDtmd1jNcMOtvHoqz0_nnd4s45FeIHfGcPlY2tYYpoHZEG0zp0xxVJokyGZknSY3eUkCnYuPKGmltKJy0pbfKS10Xmc8eiaN20-ITAb42TFR0OkUpa2lKpTQmKIup98z5IvFq_-6ri0FGo9rRD6UqtlEVbBSJx8Ewv6oxqFNZJCZsqIr9jmzgyAtcNctZG4ggE3VwEgz4j-dP9tatgrN2nIkzLWnwpYrEy7GYO-ADaC1utlyHoA9h14yHOEyGsaOUFrFc6zwS-mCajBVYwvuwpG3WOylvxYmiEvX0_0b_TNzm22EHaCKO-sstPidM1NsXO4_4CdvWAOc
  priority: 102
  providerName: Hindawi Publishing
– databaseName: AUTh Library subscriptions: ProQuest Central
  dbid: BENPR
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwhV3da9RAEF-0pdIX8bvRq6xQ3wy9JLvZ5Emu5cohXBG1eG9hPyZcwCZnk1P65L_uzGUvbUX0LbCb3STz-ZudzDB2NLbalcKgpAGKm4iFCzOjVajGqZVaGzSiFIecn6ezC_FhIRc-4Nb6tMqtTtwoatdYipEfUzJBHqcql-9X30PqGkWnq76Fxn22G0eCjml3T6bnHz8NkAu9G9X_EolIKVaLbeq7lLhglB0Lah9OVXZuGaU9uNR4oQclvbckePyz-psT-mcu5S3jdPaIPfReJZ_0bPCY3YP6CXsw9-fmT9mvKVWK0Paa69rxz7qE7po3Jf8KFT-p-Byqd1xz6qUNLfAZfmpOioJaLuFAi3fxyTcfOvwBvGvwrvZy3S05-rx8eqWdD_3RomjJkL3Mpgw0X1FAoHrGLs6mX05noW-9EFqEQF0oTWw0oUNlEVHo3MUpyEQgmtIijaISnEFbj8Pa5iWg2sisMLkz0glVZolLnrOduqnhgHFXasIwKh6DEKXQuZQKIhDZ2DmCgwF7u_32xaqvsFFskImUBdGo8DQK2AtPmJtp5O_JJGAjIlRBIok0sCggtpikVDYIvSnc4MgT8D_rj7bULbwct8UN1wXszTBMG1BuWg3NmuagV4RubUKP2DPDsFGM-i1VKg2YusMmwwSq7n13pK6WmyrfknpIRfLlvx_rFdunl-iDQiO2012t4RDdpM689rLwG0luDJA
  priority: 102
  providerName: ProQuest
– databaseName: Scholars Portal Open Access Journals
  dbid: M48
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwhV1Nj9MwELVWixZxQXwTKMhIy41A49hxckCooK4qpHKBit4iO56okXbTpU2BnvjrzCROoKsV3CLZjhPPjOe9iTPD2Om4MK6UFi0N0NykkC5MrdGhHieFMsaiE6U45PxTMlvIj0u1PGJ9tVG_gNtrqR3Vk1pszl___LZ_hwb_tjV4pZC_R-kbSYXAKf_nDSFjSbo-l8P3BIEoR3e_RiJjEnrZH4G_MvrAOZ3AhcELM2zWJyuiyT-q68Do1TOVfzmpszvstkeXfNKpw112BPU9dnPuv5_fZ7-mlDHCFHtuasc_mxKaPV-X_CtU_H3F51C94oZTTW3YAp_hknPaMKj0EjZscRSfnPsQ4nfgzRpHbS92zYoj9uXTjXE-BEg3RY-GambbdND8kgID1QO2OJt--TALfQmGsEAq1ITKCmuIJeoCmYXJnEhAxRJZlZFJFJXgLPp8bDZFVgJuH2khbeasclKXaezih-y4XtfwmHFXGuIyWoxBylKaTCkNEch07BzRwoC97Nc-v-wybeQtQ1EqJxnlXkYBe-QF86cb4T4VB2xEgspJWVAGBRpKkU8SSh-EqAonOPUC_M_9R710814dqVinyPDhMxWwF0MzTUBn1GpY76gPoiOEtzE9YqcMw0QC97lE6yRg-kBNhg6U5fuwpa5WbbZvRbWkIvXk3y_3lN2il-iCQyN23Gx28AzhUmOft5bwG-SzDJo
  priority: 102
  providerName: Scholars Portal
Title Efficacy and Safety of Wei Bi Mei, a Chinese Herb Compound, as an Alternative to Bismuth for Eradication of Helicobacter pylori
URI https://search.emarefa.net/detail/BIM-1155153
https://dx.doi.org/10.1155/2018/4320219
https://www.ncbi.nlm.nih.gov/pubmed/29636776
https://www.proquest.com/docview/2002926795
https://search.proquest.com/docview/2024016339
https://pubmed.ncbi.nlm.nih.gov/PMC5832115
Volume 2018
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1La9tAEF6SlJReQp-pUtdsIb1VsSXtaqWjExRMQCGkDVVPYl_Cglg2sdySU_96Z-SVm5RCoRfbaJ_WzOzMNxrNEHI81tJUTIGkWRA3FjLjJ0oKX4xjzaVUoETRD5lfxtMbdlHwYofw_l2YLmhfq_qkuZ2fNPWsi61czvWojxMbXeVnHMvrBHy0S3ZFFPUQ3aEsMGjE5i1IAEehKPpod84B6AfJiGHF8ACzhYbAfLHAbCMPVNK-nUv4IbdH9P4MwfGP-m8m6J-RlA9U0_lzcuBsSjrZ7P0F2bHNS_I0d0_NX5GfGeaJkPqeysbQz7Ky7T1dVPSrrelpTXNbf6KSYiVtu7J0Cjea4jGBBZegYQWj6OTWOQ6_W9ouYNRqvm5nFCxemt1J4xx_OCnoMWAu1SWBpkt0B9Svyc159uVs6rvCC74GANT6XIVKIjYUGvCETE0YWx4xwFKSxUFQWaNA00Oz1Gll4dBINFOpUdwwUSWRid6QvWbR2LeEmkoighHh2DJWMZlyLmxgWTI2BsGgRz72975cbvJrlB0u4bxEcpWOXB45dIT53Q2tPR55ZICEKlEggQYaxEOXkxiTBoEtBQscOwL-Y_5BT93SSfEKS3SGKWw-5R75sG3GBTAyrbGLNfYBmwiM2gi3uGGG7UI9g3lEPGKTbQfM7f24BVi-y_HtWPzov0e-I8_w_228RQOy196t7Xuwn1o1BKkpxJA8mUwusm_wfZpdXl3D1Zwl8Hk9LYadRP0CszkaIA
link.rule.ids 230,315,733,786,790,869,884,891,2236,12083,21416,24346,27955,27956,31752,31753,33777,33778,43343,43838,53825,53827,74100,74657
linkProvider National Library of Medicine
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwhV1Lb9NAEF5BUaGXilepaYBFKjesxvau1z5VAaUK0PRCK3Jb7cuKJWqH2gH1xF_vjL1JWoTgZmlftuf5jcczhBwOjbIF0yBpDsSNxcyGmVYiFMPUcKU0GFGMQ07P0skF-zzjMx9wa3xa5Uondora1gZj5EeYTJDHqcj58eJHiF2j8Ouqb6FxnzxgScKQz8VsA7jAtxH9D5GAk2IxWyW-cw7bRdkRw-bhWGPnlknadpcKLtRaRW_PERz_Kv_mgv6ZSXnLNJ08Jrvep6SjngmekHuuekoeTv1X82fk9xjrRChzTVVl6VdVuPaa1gX95kr6oaRTV76nimInbdc4OoEXTVFNYMMlGGhgFR1994HDn462NaxqLpftnILHS8dXyvrAH24KdgyYS3dFoOkCwwHlc3JxMj7_OAl944XQAABqQ65jrRAbCgN4QuU2Th1PGGApxdIoKpzVYOlhWJm8cKA0MsN0bjW3TBRZYpM9slXVldsn1BYKEYyIh46xgqmcc-Eix7KhtQgGA_Ju9e7loq-vITtcwrlEGklPo4C88ITZTENvjycBGSChJAok0MCAeBg5SrFoEPhScMChJ-B_9h-sqCu9FDdyw3MBebsexgMwM61y9RLngE8ETm2Ct9gzw_qgGLRbKkQaEHGHTdYTsLb33ZGqnHc1vjl2kIr4y3_f1hvyaHI-PZWnn86-HJAdfKA-PDQgW-3V0r0Ch6nVrzupuAF24A4X
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwhV1Zb9NAEF5BUSteqnIVlwCLVN6w4mPXaz9VKSQKRyokqMibtZcVS9QOtQPqE3-9M_YmaRGCN0t72Z7zG49nCDkOtDQFUyBpFsSNRcz4qZLCF0GiuZQKjCjGIWdnyfScfZjzuct_alxa5Vondora1Bpj5ENMJsiiRGR8WLi0iM_vJifLHz52kMIvra6dxl1yD6xkgG0cxHwLvsDPEf3PkYCZIjFfJ8FzDluH6ZBhI3Gst3PDPO3aCwkXcqOudxcIlH-Vf3NH_8yqvGGmJgdk3_mXdNQzxANyx1YPyd7MfUF_RH6PsWaE1FdUVoZ-kYVtr2hd0G-2pKclndnyDZUUu2rbxtIpvHSKKgObL8FAA6vo6LsLIv60tK1hVXOxahcUvF86vpTGBQFxU7BpwGiqKwhNlxgaKB-T88n469up75ow-BrAUOtzFSmJOFFowBYyM1FiecwAV0mWhGFhjQKrD8NSZ4UFBZJqpjKjuGGiSGMTPyE7VV3Zp4SaQiKaEVFgGSuYzDgXNrQsDYxBYOiR1-t3ny_7Wht5h1E4z5FGuaORRw4dYbbT0PPjsUcGSKgchRNooEFUdD5KsIAQ-FVwwLEj4H_2H6ypmzuJbvIt_3nk1WYYD8AstcrWK5wD_hE4uDHeYs8Mm4Mi0HSJEIlHxC022UzAOt-3R6py0dX75thNKuRH_76tl2QPBCL_9P7s4zNyH5-njxQNyE57ubLPwXdq1YtOKK4BW3oSQw
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Efficacy+and+Safety+of+Wei+Bi+Mei%2C+a+Chinese+Herb+Compound%2C+as+an+Alternative+to+Bismuth+for+Eradication+of+Helicobacter+pylori&rft.jtitle=Evidence-based+complementary+and+alternative+medicine&rft.au=Li%2C+Lei&rft.au=Meng%2C+FanDong&rft.au=Zhu%2C+Shengtao&rft.au=Guo%2C+ShuiLong&rft.date=2018-01-01&rft.pub=John+Wiley+%26+Sons%2C+Inc&rft.issn=1741-427X&rft_id=info:doi/10.1155%2F2018%2F4320219&rft.externalDocID=A604313551
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1741-427X&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1741-427X&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1741-427X&client=summon